

© 2024 LYNX-Werbemitteilung - Bitte beachten Sie den Haftungsausschluss
Realtime | Geld | Brief | Zeit |
---|---|---|---|
82,80 | 83,00 | 31.03. | |
82,70 | 83,30 | 31.03. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mo | Merck Says Winrevair Reduced Risk Of Death, Lung Transplantation And Hospitalization For PAH | KENILWORTH (NJ) (dpa-AFX) - Merck (MRK), known as MSD outside of the United States and Canada, Monday announced the first presentation of results from the Phase 3 Zenith trial evaluating Winrevair... ► Artikel lesen | |
Mo | Merck's Winrevair slashes mortality-morbidity risk by 76% | ||
Mo | Winrevair zeigt vielversprechende Ergebnisse in PAH-Studie, so Merck | ||
Mo | St. James Investment Company LLC Has $9.72 Million Stake in Merck & Co., Inc. (NYSE:MRK) | ||
So | Notable healthcare headlines for the week: J&J, GSK, Merck, and Cassava Sciences in focus |